國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Targeted intracellular drug delivery...

D'Souza, Anisha A.

Targeted intracellular drug delivery by receptor mediated endocytosis

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeted intracellular drug delivery by receptor mediated endocytosisedited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza.
其他作者:	Devarajan, Padma V.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xviii, 560 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Drug delivery systems.
電子資源:	https://doi.org/10.1007/978-3-030-29168-6
ISBN:	9783030291686$q(electronic bk.)

Targeted intracellular drug delivery by receptor mediated endocytosis
Targeted intracellular drug delivery by receptor mediated endocytosis[electronic resource] /edited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza. - Cham :Springer International Publishing :2019. - xviii, 560 p. :ill. (some col.), digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.392210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

Part 1-Introduction and overview -- Intracellular Delivery in Cancer and Infectious Diseases -- Intracellular Delivery by Receptor Mediated Endocytosis -- Part 2-Receptor and Receptor Medicated Endocytosis in Cancer -- Receptors Relevant for Cancer Therapeutics -- (chapters 3-8) -- Part 3-Receptors and Receptor Medicated Endocytosis in Infectious Diseases -- Receptors Relevant for Infectious Disease Therapeutics -- (chapters 9-13) -- Part 4-Common Receptors for Receptors and Receptor Mediated Endocytosis in Cancer and Infectious Diseases -- Chapters 14-17) -- Receptors Relevant for Cancer and Infectious Disease Therapeutics -- Part 5-Models for Evaluation of Targeted Delivery in Cancer and infectious Diseases -- In vitro and in vivo Models for Cancer and Infectious Diseases -- In vitro and in vivo Models for Infectious Diseases -- Part 6- Regulatory and Toxicity Issues -- Regulatory and Toxicity Issues in Targeted Delivery.

This book elaborates on various aspects of targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in Targeted Drug Delivery: Concepts and Applications. Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. Many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defective cellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery. While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases. Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosis discusses the major receptors that are useful for targeted delivery for these afflictions. An overview of pathways of intracellular uptake is presented with emphasis on RME pathways. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also clinical trials, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. This section also includes a chapter on cellular assays which was conceived to provide hands on training to young and nouveau researchers in the field of targeted nanomedicine.

ISBN: 9783030291686$q(electronic bk.)

Standard No.: 10.1007/978-3-030-29168-6doiSubjects--Topical Terms:

196465
Drug delivery systems.

LC Class. No.: RS199.5 / .T374 2019

Dewey Class. No.: 615.6

Targeted intracellular drug delivery by receptor mediated endocytosis
LDR:04413nmm a2200337 a 4500 001 569297
003 DE-He213
005 20200204115122.0
006 m d
007 cr nn 008maaau
008 200723s2019 sz s 0 eng d
020 $a 9783030291686$q(electronic bk.)
020 $a 9783030291679$q(paper)
024 7 $a 10.1007/978-3-030-29168-6 $2 doi
035 $a 978-3-030-29168-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5 $b .T374 2019
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .T185 2019
245 0 0 $a Targeted intracellular drug delivery by receptor mediated endocytosis $h [electronic resource] / $c edited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xviii, 560 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.39
505 0 $a Part 1-Introduction and overview -- Intracellular Delivery in Cancer and Infectious Diseases -- Intracellular Delivery by Receptor Mediated Endocytosis -- Part 2-Receptor and Receptor Medicated Endocytosis in Cancer -- Receptors Relevant for Cancer Therapeutics -- (chapters 3-8) -- Part 3-Receptors and Receptor Medicated Endocytosis in Infectious Diseases -- Receptors Relevant for Infectious Disease Therapeutics -- (chapters 9-13) -- Part 4-Common Receptors for Receptors and Receptor Mediated Endocytosis in Cancer and Infectious Diseases -- Chapters 14-17) -- Receptors Relevant for Cancer and Infectious Disease Therapeutics -- Part 5-Models for Evaluation of Targeted Delivery in Cancer and infectious Diseases -- In vitro and in vivo Models for Cancer and Infectious Diseases -- In vitro and in vivo Models for Infectious Diseases -- Part 6- Regulatory and Toxicity Issues -- Regulatory and Toxicity Issues in Targeted Delivery.
520 $a This book elaborates on various aspects of targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in Targeted Drug Delivery: Concepts and Applications. Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. Many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defective cellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery. While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases. Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosis discusses the major receptors that are useful for targeted delivery for these afflictions. An overview of pathways of intracellular uptake is presented with emphasis on RME pathways. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also clinical trials, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. This section also includes a chapter on cellular assays which was conceived to provide hands on training to young and nouveau researchers in the field of targeted nanomedicine.
650 0 $a Drug delivery systems. $3 196465
650 0 $a Endocytosis. $3 194347
650 1 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Pharmacy. $3 218145
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Infectious Diseases. $3 274275
700 1 $a Devarajan, Padma V. $3 712743
700 1 $a Dandekar, Prajakta. $3 619157
700 1 $a D'Souza, Anisha A. $3 855233
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 559046
856 4 0 $u https://doi.org/10.1007/978-3-030-29168-6
950 $a Biomedical and Life Sciences (Springer-11642)